Search - Prime Therapeutics

388 Results for GLP-1 Pipeline Update

Looking to lose weight in 2024? Watch for counterfeit GLP-1 drugs

Jessica Johnson, clinical consultant at Prime's Special Investigations Unit, shares how to identify fake GLP-1s

PA Sub-Categories: GLP-1 Prime Article: Perspectives
AMCP Nexus in focus: Exploring Prime’s GLP-1 research in depth

Ben Urick, senior director of health outcomes, and Landon Marshall, health outcomes research principal, share more about their educational session and research poster on GLP-1s

PA Sub-Categories: GLP-1 Prime Article: Perspectives
BioSpace: GLP-1 Side Effects Only One Factor Driving Patient Discontinuation Rates

BioSpace: While drug developers work to mitigate the side effects associated with GLP-1–based obesity drugs, recent studies reveal that myriad variables are causing patients to stop treatment

PA Sub-Categories: GLP-1 Prime Article: In the News
Prime continues to lead industry on GLP-1 research: 1 in 7 stays on GLP-1 drugs for weight loss after two years

Real-world, integrated data follows-up on previous insights, analytics.

PA Sub-Categories: GLP-1 Prime Article: Press Releases